# Sqmedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sqmedical

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.sqmedical.com
- Total disclosed funding: $15M
- Latest round: Series C (Aug 24, 2020)
- Investors on record: 5

## About

Established in 2014 and based in Shanghai, China, Sqmedical operates as a medical company that focuses on the research and development of vascular minimally invasive interventional products. The company has a branch office in Puxi, as well as an associate company, Beijing hatekaier Medical Technology. In 2021, it began the construction of the company's Pudong production base. In August 2020, Sqmedical raised a strategic investment for approximately CNY 100 million led by new investors Lyfe Capital and GL Ventures, with participation from returning investors 3H Health Investment and Apricot Capital.

Sqmedical mainly engages in the research, development, production, and sales of medical devices. Its products include drug-coated coronary balloon catheters and detachable spring coil embolization systems with fiber hair. The drug-coated coronary balloon catheter utilizes sound-coating technology. Products can be used in cardiovascular intervention, structural heart disease, peripheral vascular intervention, and neurovascular intervention.

## Funding rounds

- Series C, Aug 24, 2020, $15M — LYFE Capital, Apricot Capital, 3H Health Investment, GL Ventures
- Series B, Jun 2, 2020 — Hardy Farm Ventures, 3H Health Investment
- Series A, Nov 14, 2019 — Apricot Capital

## Investors

- Apricot Capital (https://capitalatlas.ai/funds/apricot-capital) — Series A, Series C
- Hardy Farm Ventures — Series B
- 3H Health Investment (https://capitalatlas.ai/funds/3h-health-investment) — Series B, Series C
- LYFE Capital — Series C
- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series C